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Abstract
Toll and Toll-like receptors represent families of receptors involved in mediating innate immunity response in insects and
mammals. Although Drosophila proteome contains multiple Toll paralogs, Toll-1 is, so far, the only receptor to which an
immune role has been attributed. In contrast, every single mammalian TLR is a key membrane receptor upstream of the
vertebrate immune signaling cascades. The prevailing view is that TLR-mediated immunity is ancient. Structural analysis
reveals that Drosophila Toll-9 is the most closely related to vertebrate TLRs and utilizes similar signaling components as Toll-
1. This suggests that Toll-9 could be an ancestor of TLR-like receptors and could have immune function. Consistently, it has
been reported that over-expression of Toll-9 in immune tissues is sufficient to induce the expression of some antimicrobial
peptides in flies. These results have led to the idea that Toll-9 could be a constitutively active receptor that maintain
significant levels of antimicrobial molecules and therefore provide constant basal protection against micro-organisms. To
test theses hypotheses, we generated and analyzed phenotypes associated with a complete loss-of-function allele of Toll-9.
Our results suggest that Toll-9 is neither required to maintain a basal anti-microbial response nor to mount an efficient
immune response to bacterial infection.
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Introduction
Innate immunity is a rapid and efficient response that multicel-
lular organisms mount to defend themselves against infection and
that has been conserved throughout evolution (reviewed in [1,2]).
Upon infection, microbe-specific immune elicitors, known as
microbe-associated molecular patterns (MAMPs), are recognized
by a set of so-called pathogen recognition receptors (PRRs) [3,4].
Mainlythroughgeneticscreens,theDrosophilacommunityhaslargely
contributed to the molecular dissection of the signaling modules that
regulate expression of immune genes following infection. Drosophila
humoralimmuneresponseisunderthe transcriptionalcontroloftwo
NF-kB signaling cascades,the Immune deficiency(Imd) and the Toll
pathways,whichcloselyresemblemammalianTNF-RandToll-Like
Receptor (TLR), respectively (reviewed in [5,6]). The Imd pathway
can be activated by Gram-negative bacteria that contain diamino-
pimelic acid type peptidoglycan (DAP-type PGN) in their cell wall.
Binding of DAP-type PGN to the transmembrane receptor
Peptidoglycan-Recognition-Receptor-LC (PGRP-LC) induces phos-
phorylation and proteolytic activation of the NF-kB/Rel transcrip-
tion factor Relish. This, in turns, activates the expression of several
antimicrobial peptides (AMPs), such as Diptericin [2,7,8]. The Toll
pathway is triggered by Gram-positive bacteria with Lysine-type
peptidoglycan (Lys-type PGN), fungi and yeast, and mediates
phosphorylation and subsequent degradation of the IkB-like
inhibitor Cactus, freeing the NF-kB transcription factor Dif that
translocates into the nuclear compartment where it induces the
expression ofseveralgenesencoding AMPs,including Drosomycin and
Cecropin [9–13].
The Toll (also known as Toll-1) gene was originally isolated for its
role in specifying dorso-ventral polarity of the Drosophila embryo [14].
Toll encodes a type I transmembrane receptor composed of three
domains: the extracellular leucine-rich repeats (LRR) domain,
containing tandem arrays of a short leucine-rich motif in the N-
terminal region, a sequence likely to form a single transmembrane
helix, and an intracellular C-terminal domain significantly related to
the vertebrate interleukin-1 receptor (the Toll-interleukin receptor -
TIR- domain), involved in signaling processes [15–17]. Although it is
well established that vertebrates TLRs function as PRRs for numerous
microbial ligands such as LPS, dsRNA, Flagellin, DNA CpG
(reviewed in [18,19]), there are so far no indication that Drosophila
Toll family members are able to directly recognized microbial motifs.
How then is the Toll receptor activated by bacterial PGN in flies?
Recognition of bacterial PGN by PGRP-SA triggers a proteolytic
cascade whose last substrate is the circulating pro-cytokine Pro-Spa ¨tzle
[20,21]. This proteolytic cleavage transforms the immature cytokine
Spa ¨tzle into an active ligand which triggers Toll receptor dimerization
[22–24]. Receptor dimerization allows the recruitment of an
adaptator complex containing three intracellular Death domain-
containing proteins, MyD88, Tube and Pelle [12,25,26]. Then, by a
still unknown mechanism, Cactus is phosphorylated, allowing the
release of the Dif transcription factor [27,28].
In addition to the family founder Toll-1, the Drosophila genome
contains 8 additional members: Toll-2 also known as 18-Wheeler,
and Toll-3 to Toll-9 [29,30], the function of some of which have
been recently studied. Toll-8, also known as Tollo, is required for
the induction of neural specific glycosylation in the Drosophila
embryo [31,32]. Initially thought to be the membrane receptor
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function in the embryonic epithelium by regulating cell apical
constriction via the Rho-GTPase-signaling pathway [30]. More
recently, by analyzing double loss-of-function mutants, Yagi et al.
showed that 18-W, Toll-7 and Toll-8 may have redundant
functions in regulating developmental processes [33]. Although
limited to some of the Toll-related proteins, these studies tend to
indicate that the implication of Toll family members in immunity
is rather the exception (Toll-1) than the rule.
Phylogenetic analysis of TIR domains indicate that, with the
exception of Toll-9, Drosophila Tolls are more closely related to each
other than to mammalian TLRs [34]. This suggests that these two
groups of receptors, Drosophila Tolls and mammalian TLRs, evolved
independently to carry distinct functions: putative cellular and
developmental roles in insects, and a role in host defense in
mammals [34]. However, Drosophila Toll-9 is structurally related to
TLRs, both in its ectodomain and in the TIR domain as it is the
only Drosophila Toll receptor that does not have N-flanking cystein-
rich motifs at the C-terminal end of the ectodomain [35,36].
Additionally,Toll-9is, with Tollandtoa less extendToll-5,theonly
Drosophila Toll able to activate immune genes transcription upon
over-expression experiments in tissue culture cells [37].
Finally, Toll-9 uses, at least in part, the same intracellular
signaling components that Toll-1 to promote Drosomycin expression
Figure 1. Knock-out of the Toll-9 locus and Toll-9 expression. (A) A complete deletion of the Toll-9 locus was generated by targeted
homologous recombination using 59 (red, II) and 39 (red, I) homology regions; the white cDNA replaced the Toll-9 locus (black box in genomic region).
(B) PCR performed on the resulting KO Toll-9 line and Oregon
R control. The primers used are localized on the genomic region (A, green). (C) Toll-9
expression is independent of commensal and infectious bacteria. Toll-9 expression measured by quantitative RT-PCR in conventionally reared wild-
type (-1- WT
CR), conventionally reared wild-type 4 hours after Erwinia carotovora carotovora 15 ingestion (-2- WT
CR inf. Ecc15 -4 h-), conventionally
reared wild-type 18 hours after Ecc15 ingestion (-3- WTCR inf. Ecc15 -16 h) and germ-free wild-type (-4- WT
GF), in whole larvae, larval gut, whole adult
and adult gut. Toll-9 is enriched in the gut of both larvae and adult, and its expression level is not dependent on commensal and infectious bacteria.
Additionally, Toll-9 is no longer expressed in Toll-9
2/2 mutant (-5-). rp49 was used as the experimental expression standard.
doi:10.1371/journal.pone.0017470.g001
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suggest that Toll-9 could be another Toll family members involved
in Drosophila immunity. In order to test the putative implication of
Toll-9 in the Drosophila immune response, we generated a Toll-9
complete loss-of-function allele and tested its ability to mount an
immune response. The following data suggest that Toll-9 is not
required to mount an efficient response to bacterial infection.
Materials and Methods
Fly stocks
y,w; P{ry
+, eyeless-FLP}6, ry
506 (#5577); y,w; P{hsp70-
FLP}11, P{hsp70-I-SceI}2B, noc
Sco/CyO (#6934) and w;
relish
E20 e
s (#9457); hs-Gal4 (#2077); Df(3L)rdgC-co2, th
1st
1in
1
kni
ri-1p
p/TM6C, cu
1Sb
1Tb
1ca
1 (#2052, deficiency that covers
Toll-9, named Def(Toll-9)/TM6C in the text) were obtained from
the Bloomington Drosophila Stock Center (http://flystocks.bio.
indiana.edu/). spz
rm7 allele has been described previously [12].
UAS-Toll-9 has been kindly provided by Tony Ip [38]. Serpent-
Gal4, UAS-mCD8GFP and lozenge-Gal4, UAS-nlsGFP were
kindly provided by Michele Crozatier. The Drosomycin-GFP and
Cecropin-GFP lines were a gift from Bruno Lemaitre [39] and
Won-Jae Lee [40] respectively. Escargot-Gal4, UAS-mCD8GFP
and Diptericin-Cherry has been described [41,42]. Axenic stocks
were either obtained and maintained as described in [43], or
obtained by growing flies on medium supplemented with
antibiotics (100 mL of antibiotics cocktail per vial: Erythromycin,
Kanamycin, Tetracyclin and Chloramphenicol, each at 10 mg/
mL final). Adult flies were then kept at 25uC on autoclaved
medium. The absence of bacteria in axenic stocks was verified by
culturing homogenates of these flies on LB plates. For all other
experiments, flies were kept on a standard cornmeal food at 25uC.
Knock-out of the Toll-9 locus
Knock-out of the Toll-9 locus has been realized by ends-out
gene targeting as described in [44]. The resulting deletion covers a
genomic region starting from 852 bp upstream of the Toll-9 ATG,
and up to 41 bp after Toll-9 stop codon. The 39 and 59 homology
regions I (2926 bp long) and II (3116 bp long), showed in red in
Figure 1, were amplified by PCR from Oregon
R genomic DNA. The
region I has been amplified using the following primers: F-
ACATGCATGCATGTGGAAGCACTCTCGATTCAGC, R-
GGGGTACCCCAGAGTTCTAGTCAGTTGTGC and con-
tains SphI and KpnI sites respectively, whereas the region II has
been amplified using the following primers: F-AGGCGCGCCTT-
CATCGGATACCCATTGAGG; R-CCCGTACGGGCGAG-
GATTCCGATAGATGCC and contains AscI and BsiWI sites.
These two DNA fragments were then cloned into the pW25 vector
(Drosophila Genomics Ressource Center), on both sides of the
miniwhite gene w
hs. This pW25-Toll-9-KO construct was then
transformed into y,w embryos using the standard procedure for P-
element [45]. Male donor flies were crossed with y,w; hsp70-FLP,
hsp70-I-SceI, noc
Sco/CyO females and the resulting progeny were
heat-shocked at 37uC for one hour twice a day, at day 2 and 3
after egg laying. Mosaic and white eyes females were then
collected from the progeny and crossed to males carrying an eyeless-
FLP transgene on X chromosome. In the resulting progeny red eye
males were screened. Out of 22.400 males, 26 red eye males were
isolated but 7 of them were sterile. Genomic deletion of the Toll-9
locus and replacement with the w
hs gene were investigated by
PCR, using 5F (59-GCTGTTGACGAAGAGGGAAG-39), 5R
(GAATTGAATTGACGCTCCGT-39), 3F (59-GTCCGGTT-
GTTTTCGTGCTC-39), 3R (59-GTACACTTCCTTGGCT-
GGCG-39), 1 (59-CGTATTAGTATGCCTGTTCC-39) and 21
(59-ACAACTGACTAGAACTCTCC-39) primers as indicated in
Figure 1. Among the 19 lines established, only one showed
ampification using the primer couples 5F–5R and 3F–3R, but no
amplification using the primer couple 1–21 (Figure 1). This line
has been isogenized using y,w flies, and kept as heterozygous in the
same vial. Consequently, the control y,w has white eyes, the
heterozygous y,w; Toll-9
2/+ has orange eyes, and the y,w; Toll-9
2/
Toll-9
2 mutant has red eyes.
Hemocytes count
For each genotype (Toll-9
2/TM3GMRYFP and Toll9
2/2 larvae),
4 wandering third instar larvae were bled onto a coverslip, and the
hemocytes collected were incubated for 10 minutes in a humidified
chamber to allow them to adhere to the slide, and then fixed in PFA
4% for 5 minutes. The cells were thereafter rinsed 3 times in PBS
and mount in Vectashield with DAPI. The results are the mean of 4
different experiments, and each experiment is the mean of 3 counts.
Longevity assays
Assays for longevity were performed on normal food or on food
supplemented with an antibiotics cocktail. For each genotype (y,w,
Figure 2. Toll-9
2/2 mutant emerging length is delay and lifespan is reduced. (A) Toll-9
2/2 mutant emergence is delayed of one day
compared to wild-type +/+ and heterozygous Toll-9
2/+. (B) Toll-9
2/2 and Toll-9
2/Def(Toll-9) mutant lifespan is reduced. Median survival is of 32 and
27 days respectively for mutants and 42 days in controls. This reduction is still observed if flies grown on food supplemented with antibiotics (29 in
Toll-9
2/2 versus 41 days in controls).
doi:10.1371/journal.pone.0017470.g002
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2/2 and Toll-9
2/Def(Toll-9)) at least 80 flies grouped by 10
males in independent vials were tested.
Immunocytochemistry
Immunocytochemistry was performed as previously described
(McKearin and Ohlstein, 1995). The mouse anti-Delta (1:20,
Developemental Studies Hybridoma Bank), and chicken anti-GFP
(1:500, Aves Labs) were used in this study. Fluorescence-
conjugated secondary antibodies were purchased from Interchim
Jackson (Alexa546 goat anti-mouse IgG antibody) and Molecular
probes (Alexa488 goat anti-chicken antibody), and used at a 1:500
dilution. For DNA labeling, tissues were incubated with 1 mg/mL
of DAPI (Sigma). All samples were mounted in Vectashield
mounting medium (Vectorlabs) and examined using an apotome
microscope (Zeiss Axioplan 2). Images were acquired using
AxioImager and composite figures were prepared using Adobe
Photoshop CS3.
Quantitative Real-Time PCR
To quantify the gene expression, fluorescence real-time PCR
was permormed using the double-stranded DNA-dye SYBR
Green (From Invitrogen). Primer pairs for Toll-9 (sense, q5, 59-
CCACTCTGGAAATGGCCTTA-39; antisense, q3, 59-GGTAA-
ATCAGTTCCGGCAGA-39), Diptericin (sense, 59-GCTGCG-
CAATCGCTTCTACT-39; antisense, 59-TGGTGGAGTGG-
GCTTCATG-39), Drosomycin (sense, 59-CGTGAGAACCTTTT-
CCAATATGATG-39; antisense, 59-TCCCAGGACCACCAG-
CAT-39), Defensin (sense, 59-GTTCTTCGTTCTCGTGG-39;
antisense, 59-CTTTGAACCCCTTGGC-39), Drosomycin3 (sense,
59-CAGATGATATTCCTGTTTGCT-39; antisense, 59-TGTC-
CCTCCTCAATGC-39), rp49 (sense, 59-GACGCTTCAAGG-
GACAGTATCTG-39; antisense, 59-AAACGCGGTTCTGCAT-
GAG-39), were used to target gene transcripts. All samples were
analyzed in triplicates, and the levels of detected RNA were
normalized using rp49 as a control.
Figure 3. Hematopoiesis occurs normally in Toll-9
2/2 mutant embryos. Serpent-GFP and Lozenge-GFP expression in stages 5, 7, 11 (side
views) and 13 (dorsal views) of control (A, B, C, D, Srp-GFP; and I, J, K, L, Lz-GFP, respectively) and Toll-9
2/2 (E, F, G, H, Srp-GFP; and M, N, O, P, Lz-GFP,
respectively) embryos. The Srp transcription factor is expressed in hemocytes precursors, which will differentiate into plasmatocytes and crystal cells.
The AML-1/Runx1 homolog Lz is required for crystal cell differentiation and expressed in a subset of prohemocytes. During blastoderm stage, Srp is
expressed in the yolk nuclei (A). After gastrulation and thenafter, Srp expression is found in the putative hemocyte primordium within the anterior
mesoderm primordium (B, C, D, arrowheads), and in the primordium of the posterior midgut (B, C, arrows). Lz is first detected in stage 10, in a small
cluster of cells within the head mesoderm (K, L), corresponding to the crystal cells precursors, a subset of Srp-expressing hemocyte precursors. The
Srp- and Lz- expressing cells in Toll-9
2/2 mutant embryos are numerically, morphologically and spatially unchanged compared to wild-type.
doi:10.1371/journal.pone.0017470.g003
Lack of Immune Response in Toll-9 Mutant
PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e17470Bacterial strains and infection experiments
Bacterial strains used were Escherichia coli, Erwinia carotovora
carotovora 15, Pseudomonas entomophila, Lactobacillus plan-
tarum, Serratia marcescens and Enterococcus faecalis. Systemic
bacterial infections were performed by septic injury, consisting of
wounding the adult thoracic cuticle with a needle previously
dipped into a concentrated bacterial solution (OD=200 for E. coli
and Ecc15, and OD=20 for E. faecalis). Larval oral infections
were performed by adding 200 mL of concentrated bacteria
solution (OD=200) directly on L2-L3 larvae. Adult oral infections
were performed by letting flies feed on a 2.5% sucrose solution
contaminated with concentrated bacteria (final OD=100).
Results
Phenotypic characterization of Toll-9 mutant
In order to study Toll-9 receptor function, we generated a
complete loss-of-function allele by targeted homologous recombi-
Figure 4. Basal AMP mRNA levels are identical in wild-type and Toll-9
2/2 mutants. (A–B) AMPs expression in larvae overexpressing Toll-9.
Drs-GFP (A, A’) and Dpt-Cherry (B, B’) expression in Drs-GFP; hs-GAL4/UAS-Toll9 and hs-GAL4/UAS-Toll9; Dpt-Cherry larvae respectively, after a heat-
shock treatment. Overexpressing Toll-9 in the larva using a constitutive driver leads to the ectopic expression of Drosomycin, but not Diptericin. (C–F)
Quantitative RT-PCR analysis of AMPs production in unchallenged Toll-9
2/2 mutants whole larvae (C), whole adult (D), larval gut (E) and adult gut (F)
compared to control. Diptericin (C–F), Drosomycin (C, D), Defensin (C–F) and Drosomycin3 (E, F) expression were not significantly different in a Toll-9
2/2
mutant background compared to controls (for each experiment, P$0.06). Relative AMP/rp49 ratios of controls were set to 1 to indicate fold induction.
doi:10.1371/journal.pone.0017470.g004
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into the pW25 vector (Figure 1A) to generate transgenic flies. The
Toll-9 gene disruption knock-out candidate flies were screened and
verified using PCR (with specific primers in the two flanking regions
of Toll-9 -5F and 3R-, within Toll-9 -1 and 21- and within w
hs -5R
and 3F-, Figure 1A, B) and quantitative PCR (using q5 and q3
primers, Figure 1C, D). Toll-9
2/2 mutants in which both maternal
and zygotic contributions have been removed hatched into
morphologically normal and fertile adults, although the Toll-9
2/2
flies emerged one day later than the w control. Indeed, the t50 (time
by which 50% of the progeny has emerged) is of 10.7 days for the
control and of 11.6 days for Toll-9
2/2 (Figure 2A). Moreover, Toll-
9
2/2 and Toll-9
2/Def(Toll-9) flies showed a reduced lifespan
(Figure 2B) with the mean lifespan of w control flies being at 42 days
versus 32 and 27 days for Toll-9
2/2 and Toll-9
2/Def(Toll-9) mutant
flies, respectively. A similar lifespan shift was observed when flies are
grown in axenic conditions (Figure 2B). Finally, an embryonic
lethality was observed, since only one third of the expected
Toll-9
2/2 embryos hatched into larvae. The analysis of the dead
embryos revealed that the lethality occurs at the end of
embryogenesis. In conclusion, loss of Toll-9
2/2 function is
associated with partial embryonic lethality, delay in adult flies
emergence and reduced lifespan.
Toll-9 expression is highly spatially and temporally restricted
during embryogenesis [46]. It starts at stage 5 in the vitellophages
and is, from stages 7 to 11, limited to a group of cells in the head
region, located at the site where the hemocytes progenitors are
specified. Later in embryogenesis, Toll-9 transcripts are no longer
detectable [46]. Knowing that hemocytes are essential for normal
embryogenesis to take place and are playing essential roles in
immunity [42,47,48], we checked whether the embryonic
hemocyte population was affected in Toll-9
2/2 mutants. For that
purpose, we monitored the expression of two hematopoietic
markers, Serpent, a GATA transcription factor expressed in
hemocytes precursors which will differentiate into plasmatocytes
and crystal cells, and Lozenge, an AML-1/Runx1 homologue
required for crystal cell differentiation and expressed in a subset of
prohemocytes [49,50]. As showed in Figure 3, both factors were
expressed normally in Toll-9
2/2 mutant embryos (even at the end
of embryogenesis, data not shown), suggesting that the embryonic
hematopoiesis is not affected by the absence of Toll-9. This was
further confirmed by counting the number of larval hemocytes.
We found that the number of larval hemocytes was slightly
increased in Toll9
2/2 mutants. Indeed, we found 17756238
hemocytes per mm
2 (n=11420) in Toll-9
2/2 mutant larvae,
compared to 12426138 hemocytes per mm
2 (n=7990) in Toll-
9
2/TM3GMRYFP control larvae (less than a 2-fold increase). It is
however unlikely that this increase of embryonic hemocytes could
explain the partial embryonic lethality observed in Toll-9
2/2
stocks.
Figure 5. Epithelial AMP expression pattern is identical in wild-type and Toll-9
2/2 mutants. (A–B) In unchallenged adult flies (A, B),
Cecropin-GFP constitutive expression observed in the labellar glands (A’, B’) and in the dissected spermathecae (A’’ and B’’) is unchanged in the Toll-
9
2/2 mutant. 18 hours after Ecc15 ingestion, Drosomycin-GFP (C, D) and Diptericin-Cherry (E, F) are similarly expressed in the fat body of Toll-9
2/2
mutant and control larvae.
doi:10.1371/journal.pone.0017470.g005
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AMP production
It has been shown that Toll-9 overexpression in vitro and in vivo is
sufficient to induce the expression of antimicrobial peptides genes
known to be regulated by the Toll pathway, such as Drosomycin or
Cecropin ([37,38] and Figure 4A, A’), but not Diptericin, an Imd
pathway regulated gene (Figure 4B, B’). This work had led to the
idea that Toll-9 functions as a constitutively active signaling
receptor that will maintain a substantial level of antimicrobial
peptides required to ward off continuous challenge of microor-
ganisms.
We then wanted to test whether Toll-9 expression was
dependent on the presence of either commensal or pathogenic
bacteria. We therefore compared Toll-9 transcript levels between
flies grown in axenic conditions, conventionally-reared flies, and
flies infected with the phytopathogenic bacteria Erwinia carotovora
Figure 6. Systemic AMP production is independent of Toll-9 function. Quantitative RT-PCR analysis of AMPs induction after Gram-negative
bacteria ingestion. Diptericin (A. C, E), Drosomycin (B, D) and Drosomycin3 (F) expression upon Ecc15 oral ingestion in Toll-9
2/2 whole larvae (A, B),
whole adults (C, D), and adult gut (E, F), and in relish
E20 whole adult (C, D), and adult guts (E), compared to control. rp49 was used as the experimental
expression standard. Relative AMP/rp49 ratios of unchallenged controls were set to 1 to indicate fold-induction.
doi:10.1371/journal.pone.0017470.g006
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neither modified under axenic conditions nor after immune
challenge by Ecc15 (Figure 1C, D). This is in agreement with
previously published results showing that Toll-9 transcript levels
did not seem to change in the whole larvae and adult following
septic injury with Escherichia coli [37].
Among immune-competent tissues, the gut is permanently in
contact with a large number of well-tolerated commensal bacteria,
which under normal condition do not elicit an immune response.
Our results, together with microarray analysis (http://www.
flyatlas.org), indicate that Toll-9 is highly and specifically enriched
in larval and adult guts (3.3 times in the larval midgut compared to
whole larvae, Figure 1C and 13.8 times in the adult midgut,
compared to whole fly, Figure 1D). It was therefore tempting to
speculate that Toll-9 may play a role in localized epithelial defense
by maintaining a basal level of antimicrobial peptides in the gut, a
tissue in constant contact with microorganisms. We then tested
whether Toll-9 expression was modified specifically in the gut in
axenic conditions or following oral infection with Ecc15. Contrary
to Bombyx mori Toll-9, whose expression is significantly increased in
the gut by microbial challenge [51], Drosophila Toll-9 expression
levels was not significantly different in conventionally reared flies,
flies grown in axenic conditions or in immune challenged flies
(Figure 1C, D).
To further test the hypothesis that Toll-9 is required to maintain
a basal level of antimicrobial peptides, we measured the levels of
several peptides in Toll-9
2/2 mutants, in the whole animal to
quantify the systemic response, and specifically in the gut to
measure the local response. The following antimicrobial peptides
were tested: Drosomycin and Defensin, regulated by the Toll pathway,
Diptericin, regulated by the Imd pathway, and Drosomycin3, a gut
expressed gene whose transcription is JAK/STAT pathway
dependent [52]. Toll-9
2/2 mutant larvae and adults were always
compared to Toll-9
2/TM3 control larvae and +/+ control adults,
respectively, from the same vial, to avoid variations due to external
factors. Basal expression levels of Diptericin, Drosomycin, Defensin
(Figure 4C, D) in whole animals and of Diptericin, Drosomycin3 and
Defensin (Figure 4E, F) in guts were not significantly different in
controls and Toll-9
2/2 mutants (for each experiment, P$0.06).
We confirmed this result using antimicrobial peptide reporter
lines. Indeed, uninfected wild-type and Toll-9
2/2 mutants show
identical Diptericin-Cherry, Drosomycin-GFP and Cecropin-GFP expres-
sion pattern in both larvae and adult (constitutive Cecropin-GFP
expression in the adult is shown in Figure 5A, B).
The data above suggest that contrary to what has been
proposed earlier, Toll-9 is not required to maintain a basal level
of AMPs production in vivo. We then tested whether Toll-9 is
necessary to regulate immune gene induction after microbial
challenge. As Toll-9 is mainly expressed in the gut, we used the
Ecc15 oral infection model. First, we observed that the survival of
Toll-9
2/2 mutants was not affected by Ecc15 oral infection (Figure
S1). We next checked induction levels of Diptericin and Drosomycin in
whole larvae and adult, and Diptericin and Drosomycin3 expression in
the adult gut (Figure 6). Since antimicrobial peptides gut induction
has been shown to depend essentially on the Imd pathway, we
used relish
E20 as a control. Upon Ecc15 oral infection, Diptericin
expression increased up to 120-fold in whole larvae (Figure 6A),
25-fold in whole adults (Figure 6C) and 6 times in adult guts
(Figure 6E). Similar induction levels were obtained in Toll-9
2/2
mutant background (Figure 6A, C, E, for each experiment,
P$0.25), whereas, as expected, Diptericin induction was abolished
in a relish
E20 mutant (Figure 6C, E). Similarly, no significant
variation was observed for Drosomycin and Drosomycin3 induction
between wild-type and Toll-9
2/2 mutants (Figure 6B, D, F). These
results were confirmed by using reporter lines for Cecropin,
Drosomycin and Diptericin (Cec-GFP, Drs-GFP and Dpt-cherry,
respectively), both in the larvae (Figure 5C–F) and in the adult
(data not shown). To complete this analysis, we performed oral
infection using other bacteria species such as Pseudomonas
entomophila, Serratia marcescens and Lactobacillus plantarum. Twenty
hours following oral ingestion of these bacteria, Diptericin mRNAs
induction was not significantly different in Toll9
2/2 versus control
midguts (Figure S2, for each experiment, P$0.1). From these
experiments we concluded that the basal and oral infection-
Figure 7. Resistance to bacterial infection is not impaired in Toll9
2/2 adults. Survival curves of Toll-9
2/2, relish
E20 and spz
rm7, and control
flies in absence of injury, upon clean injury or after septic injury with E. coli, Ecc15 or E. faecalis.
doi:10.1371/journal.pone.0017470.g007
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2/2
inactivation. This suggests that Toll-9 does not participate in
maintaining basal expression levels of antimicrobial peptides genes
in normal conditions or after oral immune challenge.
To complete these experiments, we analyzed AMP production
and survival of Toll-9
2/2 flies infected by septic injury. Our results
showed that Toll-9
2/2 mutant flies resist as well as control flies to
clean injury and to septic injuries performed with either Gram-
positive or Gram-negative bacteria (Figure 7). We next wanted to
test whether the humoral antimicrobial response was affected in
Toll-9
2/2 infected mutant. Diptericin mRNA induction upon Ecc15
infection was similar in Toll-9
2/2 mutant and in controls (Figure
S3), indicating that Imd dependent AMP production response was
not affected by the absence of Toll-9.
Gut homeostasis is normal in Toll-9 mutant
Recent studies have revealed that bacterial infection can trigger a
gut immune response that involves the production of Reactive
Oxygen Species and antimicrobial peptides [52–55]. Associated
with this mechanism of defense, the gut epithelium triggers the
proliferationand differentiationofintestinalstemcells(ISCs,stained
withDelta (Dl) and Escargot (Esg), [52]. Upon stimulation, the ISCs
give rise to two intestinal cell types: enterocytes (young enterocytes
still express Esg) and enteroendocrine cells [56]. It has been shown
that oral infection with some bacteria species can stimulate
epithelium renewal by inducing ISCs proliferation and therefore
production of enterocytes [52,53]. We then tested whether the gut
homeostasis was modified in a Toll-9
2/2 mutant. As shown in
Figure 8, the numbers of ISCs (Esg-positive and Dl-positive cells)
and young enterocytes (Esg-positive and Dl-negative cells) were
similar in unaffected Toll-9
2/2 mutants and in control guts
(Figure 8A–A’’ and B–B’’). Upon infection, the epithelium renewal
occurred normally in a Toll-9
2/2 mutant midguts (Figure 8C–C’’
and D–D’’).These results indicate that neither the basal gut renewal
in non-infected guts nor the epithelium renewal triggered by
bacterial infection is dependent on Toll-9 function.
Discussion
Thefindingsthat TLRsareimplicated inthe immuneresponsein
mammals and that Toll participates in the Drosophila host response
has led to the idea that TLR-mediated immunity is originating from
ancestor of bilaterian (review in [18]). If such, one might expect
multiple mammalian TLRs and Drosophila Toll family members to
have immune function. If it is now clearly demonstrated that every
single mammalian TLR family member is implicated in an immune
Figure 8. Gut epithelium renewal is not affected in Toll-9
2/2 mutants. Immunostaining with antibodies against GFP (white, A–D; green, A’’–
D’’) and Delta (white, A’–D’; red, A’’ –D’’). DNA is shown in blue (A’’–D’’). Esg-GFP positive cells correspond to ISCs or young enteroblasts, whereas Dl
stains only ISCs in unchallenged adult guts (A, B). 20 hours after Ecc15 oral infection, Esg-GFP positive cell and Dl positive cell numbers strongly
increase (C–D), corresponding to an increased epithelium renewal, observed both in the control and in Toll-9
2/2 guts.
doi:10.1371/journal.pone.0017470.g008
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evidence for immune role has only been gathered for the Toll-1
protein itself[12,57,58].Incontrary,therearesome reasonstothink
that the immune implication of TLRs and Toll have been co-opted
independently in insects and mammals [36,59,60]. This hypothesis
is based on functional differences between Toll and TLR
implication in immunity, the most obvious being the difference in
their mode of activation. Whereas TLR receptors are directly
activated by versatile microbial ligands, Drosophila Toll-1 receptor
activation is dependent of the maturation of its Spa ¨tzle ligand by
proteolytic cleavage [18,61,62]. The goal of this study was to test
whether another member of the Toll family other than Toll-1 itself
couldhaveanimmunefunctioninflies.Wefocusedourattentionon
Toll-9 for two reasons. 1) Its extracellular domain organization
resembles that of the TLRs [35], and 2) published gain-of-function
experiments have previously suggested that Toll-9 could function as
a constitutively active receptor triggering basal AMP production
[37]. However, the phenotypic characterization of a complete loss-
of-function mutant presented here tends to indicate that Toll-9 is
not implicated in the antibacterial arm of the immune response.
Indeed, Toll-9 is neither required for basal and immune inducible
AMP production nor for intestinal response to oral bacterial
infection. In addition, ourresults rules out the hypothesisthat Toll-9
is triggering a constant baseline level of AMPs required to eliminate
pathogens when they enter the body cavity. We can however not
exclude that a functional Toll-9 receptor is not of importance to
mediate other aspects of the immune response such as anti-viral or
and-parasitic immunities. It is of note that the Toll signaling
pathway control anti-dengue virus in Aedes aegypti [63]. It is also
possible that Toll-9 is functionally redundant with other Toll
proteins, although the rather unique extracellular domain organi-
zation of Toll-9 let us believe that this is unlikely. What is then the
function of Toll-9? We have identified an incompletely penetrant
embryonic lethality associated with the loss of Toll-9. It is however
difficult to pinpoint the exact cause of this lethality. The only clear
phenotype associated with Toll-9 elimination is an increase of blood
cell number. It is however well know that the number of circulating
hemocytes is highly dependent on genetic background and can
strongly fluctuate even in between wild type stocks. We therefore
do not favor the hypothesis than the high hemocytes figures in
Toll-9
2/2 mutants are responsible for embryonic lethality. Further
work will be needed to dissect the precise role of Toll-9 during
embryogenesis. It should however be noted that both TLRs and
Drosophila Toll-1 have been shown to be important for non-immune
function. WhereasToll-1 is also involved inearly axis determination
and inspecifyingneuromuscularinnervation pattern, the number of
manuscripts describing TLR expression and function in the central
nervous system (CNS) has been increasing steadily and expanding
beyond their traditional roles in infectious diseases to neurodegen-
erative disorders and injury [14,64–71]. This might be a route to
follow for finding Toll-9 function!
Supporting Information
Figure S1 Toll-9
2/2 mutant survival is not affected by
Ecc15 oral infection. 7 days after oral ingestion of the Ecc15
bacteria, Toll-9
2/2 mutant flies survive as well as the control.
(TIF)
Figure S2 Gut Diptericin expression after bacteria
feeding is not modified in Toll-9
2/2 mutant. Quantitative
RT-PCR analysis of Diptericin expression in Toll-9
2/2 mutant and
control guts after oral challenge with Ecc15, Lactobacillus plantarum,
Pseudomonas entomophila and Serratia marcescens.R e l a t i v eDiptericin/rp49
ratiosofunchallenged controlswere set to 1 to indicatefold induction.
(TIF)
Figure S3 Diptericin mRNA levels after Ecc15 septic
injury are comparable in wild-type Toll-9
2/2 adults.
Quantitative RT-qPCR analysis of Diptericin mRNA 6 and 24 hours
after septic injury with Ecc15 in wild-type and Toll-9
2/2 mutant
adults. Diptericin/rp49 ratio at 6 hours post challenged was set as
100%.
(TIF)
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